DPP3 and breast carcinoma: Interestingly, analysis of 98 whole-exome samples from breast cancer patients by an integrated bioinformatics approach showed that high expression levels of DPP3 correlated with poor survival of breast cancer patients and were an independent survival determinant, making DPP3 a putative prognostic biomarker in breast cancer [94].